🔎 Trials Near Me

Home › Breast Cancer › NCT07018986

The MIND-BC Study: MIND Diet for Breast Cancer Cognition

Recruiting

Who can join

Ages 18 and older · Women

Full eligibility criteria
Inclusion Criteria:

* Previously diagnosed with stage I-III breast cancer.
* Able to speak and read English.
* Able to consume foods orally.
* \>18 years of age.
* Able to provide informed consent.
* Have no documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., schizophrenia).
* Report 'somewhat' to 'very much' cognitive impairment in the past week (i.e., a score ≥ 2 on a 0-4 scale) that they attribute to cancer or its treatment.
* Report a MIND diet score \< 10 (range 0 to 14, higher score equates to higher diet quality).
* Willing to consume the MIND diet.
* Completed adjuvant treatment 6 months to three years previously.

Exclusion Criteria:

* Not meeting all of the inclusion criteria.

About the study

This fully, powered efficacy RCT, the MIND diet for Breast Cancer Cognition (MIND-BC), will evaluate the MIND diet in a rigorous, highly controlled academic cancer center. We will recruit breast cancer survivors reporting CRCI with a MIND diet score \< 8, based on a previously devised 14-item diet questionnaire designed to detect inadequate diet with respect to brain health (scores range from 0 to 14, with lower scores indicating a less adequate diet).14 Breast cancer survivors will have recently completed adjuvant treatment (i.e., 6 months to three years previously), to ensure that perceived cognitive impairment is likely chronic and due to cancer. To achieve maximal effect, the study consists of two 12-week phases 1) intervention phase, 2) maintenance phase.

What is being tested

Sponsor: H. Lee Moffitt Cancer Center and Research Institute · Participants: 200 · Started: Jul 9, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07018986

Locations in the U.S.

FloridaMoffitt Cancer Center, Tampa

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.